SalvaRx (SALV.L) – BUY*: Intensity Therapeutics reported positive results
05 Apr 2017
Northland Capital Partners Morning Report
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Northland Capital Partners Morning Report
Salvarx Group (SALV:LON) | 0 0 (-8.6%) | Mkt Cap: 6.74m
- Published:
05 Apr 2017 -
Author:
Vadim Alexandre -
Pages:
4
SalvaRx (SALV.L) – BUY*: Intensity Therapeutics reported positive results